Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 4 minute read General business news Pharma Industry News Neuphoria Therapeutics secures milestone payment from Merck as Alzheimer’s clinical trial advances Neuphoria Therapeutics Inc. (Nasdaq: NEUP), a late-stage biotechnology company focused on developing treatments for neuropsychiatric disorders, has announced… byPallavi MadhirajuFebruary 12, 2025